Financial statements Na Rzecz Rozwoju Biotechnologii I Genetyki Polbiogen
Balance sheet of Na Rzecz Rozwoju Biotechnologii I Genetyki Polbiogen
Company age:
Age:
19 y. 7 m. 9 d.
Balance sheet data of NA RZECZ ROZWOJU BIOTECHNOLOGII I GENETYKI POLBIOGEN
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 56 448,39 | 46 521,60 | 44 282,76 | 57 652,18 | 56 718,68 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 56 448,39 | 46 521,60 | 44 282,76 | 57 652,18 | 56 718,68 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 56 448,39 | 46 521,60 | 44 282,76 | 57 652,18 | 56 718,68 |
| A. Equity | 41 381,60 | 37 462,76 | 41 652,18 | 50 718,68 | 43 610,32 |
| B. Liabilities and provisions for liabilities | 15 066,79 | 9 058,84 | 2 630,58 | 6 933,50 | 13 108,36 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | - | - |
| II. Short-term liabilities | 15 066,79 | 9 058,84 | 2 630,58 | 6 933,50 | 13 108,36 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.